The best-studied signal pathway is TGF-β signaling; research on the combined in vivo/in vitro carcinogenic model indicates that in the progression of advanced tumors, the activation of the TGF-β pathway can effectively promote the EMT process of cancer cells (45). The gene discussed is TGFB1; the disease is cancer.